Trexquant Investment LP Meridian Bioscience Inc Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$15.73 - $21.66 $196,766 - $270,944	-12,509 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$13.54 - $26.41 $169,371 - $330,362	12,509 New	12,509 $212,000
Q1 2020 May 08, 2020	SELL	$5.57 - $11.5 $124,623 - $257,301	-22,374 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$7.9 - $10.14 $176,754 - $226,872	22,374 New	22,374 $219,000
Q3 2019 Nov 08, 2019	SELL	$9.17 - $12.01 $108,976 - $142,726	-11,884 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$10.88 - $17.6 $129,297 - $209,158	11,884 New	11,884 $141,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.